Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAi agents for inhibiting expression of alpha-ENaC and methods of use

RNAi agents for inhibiting expression of alpha-ENaC and methods of use

US Patent 11214802 · Granted Jan 4, 2022

Estimated economic value: $42,476,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Determining frequency offset of signal under test2025
RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
RNAi agents for inhibiting expression of receptor for advanced glycation end-pro2025
RNAi agents for inhibiting expression of receptor for advanced glycation end-pro2025
5′-cyclo-phosphonate modified nucleotides2025
RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), 2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereo2025
RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereo2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025